A bundle of nerves

Medical experts have determined that we need to screen everyone for anxiety − and I mean everyone

- PMLiVE

Microfoundations matter

If you want to change in 2023, sweat the small stuff

- PMLiVE

MIT researchers develop AI model to detect future lung cancer risk

Lung cancer is the leading cause of cancer in the US, accounting for 1.7 million deaths globally in 2020

- PMLiVE

World Antimicrobial Awareness Week 2022

Reports from the World Health Organization show that AMR is one of the top ten threats to global health, causing 1.3 million deaths in 2019

- PMLiVE

Design considerations and best practices in clinical research

The increased focus on precision medicine in oncology and rare diseases has led to a marked increase of single-arm trials

- PMLiVE

Unlocking the potential of data sharing

The impact of privacy issues on clinical trials – how these issues limit studies and how they can be optimised

- PMLiVE

FDA approves Ferring’s Adstiladrin as first gene therapy for bladder cancer

Non-muscle-invasive bladder cancer represents around 75% of all new bladder cancer cases

- PMLiVE

ICR twin study indicates childhood leukaemia begins in the womb

The study, published in Leukemia, will help clinicians advise parents of twins with ALL

- PMLiVE

The challenges of the proposed Data Protection and Digital Information Bill

Why the new Bill may cause more complexity and confusion for businesses operating outside the UK

- PMLiVE

How and when should we innovate our strategies to deliver competitive change?

Understanding the five mistakes to avoid in order to ensure brand success

- PMLiVE

Focusing on ‘treating the patient, not the disease’ can transform the outlook for cardiovascular disease

Sharpening the focus to ‘treating the patient, not the disease’ can lead to a paradigm shift in outcomes

- PMLiVE

Retrospective prospective

Looking back at what we learned in 2022 and what the new year may bring